Literature DB >> 32436697

Classics in Chemical Neuroscience: Baclofen.

Caitlin N Kent1,2, Charlotte Park1, Craig W Lindsley1,3,2,4.   

Abstract

Baclofen, β-(4-chlorophenyl)-γ-aminobutyric acid, holds a unique position in neuroscience, remaining the only U.S. Food and Drug Administration (FDA) approved GABAB agonist. While intended to be a more brain penetrant, i.e, ability to cross the blood-brain barrier (BBB), version of GABA-aminobutyric acid) for the potential treatment of epilepsy, baclofen's highly efficacious muscle relaxant properties led to its approval, as a racemate, for the treatment of spasticity. Interestingly, baclofen received FDA approval before its receptor, GABAB, was discovered and its exact mechanism of action was known. In recent times, baclofen has a myriad of off-label uses, with the treatment for alcohol abuse and drug addiction garnering a great deal of attention. This Review aims to capture the >60 year legacy of baclofen by walking through the history, pharmacology, synthesis, drug metabolism, routes of administration, and societal impact of this Classic in chemical neuroscience.

Entities:  

Keywords:  GABAB; baclofen; epilepsy; spasticity; substance abuse

Mesh:

Substances:

Year:  2020        PMID: 32436697     DOI: 10.1021/acschemneuro.0c00254

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  9 in total

Review 1.  The glymphatic system: implications for drugs for central nervous system diseases.

Authors:  Terhi J Lohela; Tuomas O Lilius; Maiken Nedergaard
Journal:  Nat Rev Drug Discov       Date:  2022-08-10       Impact factor: 112.288

2.  Pharmacogenetics of Addiction Therapy.

Authors:  David P Graham; Mark J Harding; David A Nielsen
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Asymmetric Michael Addition in Synthesis of β-Substituted GABA Derivatives.

Authors:  Jianlin Han; Jorge Escorihuela; Santos Fustero; Aitor Landa; Vadim A Soloshonok; Alexander Sorochinsky
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

4.  Changes of Spasticity across Time in Prolonged Disorders of Consciousness: A Retrospective Study.

Authors:  Benjamin Winters; Bruce Kuluris; Rita Pathmanaban; Hannelise Vanderwalt; Aurore Thibaut; Caroline Schnakers
Journal:  Brain Sci       Date:  2022-02-21

Review 5.  GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators.

Authors:  A Nieto; T Bailey; K Kaczanowska; P McDonald
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 6.  Baclofen therapeutics, toxicity, and withdrawal: A narrative review.

Authors:  Jia W Romito; Emily R Turner; John A Rosener; Landon Coldiron; Ashutosh Udipi; Linsey Nohrn; Jacob Tausiani; Bryan T Romito
Journal:  SAGE Open Med       Date:  2021-06-03

7.  Telescoped Continuous Flow Synthesis of Optically Active γ-Nitrobutyric Acids as Key Intermediates of Baclofen, Phenibut, and Fluorophenibut.

Authors:  Sándor B Ötvös; Patricia Llanes; Miquel A Pericàs; C Oliver Kappe
Journal:  Org Lett       Date:  2020-10-07       Impact factor: 6.005

8.  Systemic and intrathecal baclofen produce bladder antinociception in rats.

Authors:  Timothy J Ness; Alan Randich; Xin Su; Cary DeWitte; Keith Hildebrand
Journal:  BMC Urol       Date:  2021-10-04       Impact factor: 2.264

Review 9.  Molecular mechanisms of metabotropic GABAB receptor function.

Authors:  Hamidreza Shaye; Benjamin Stauch; Cornelius Gati; Vadim Cherezov
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.